FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, particularly to a method for differential diagnosis of grade III and IV glial tumours. Said method involves measurement of gene expression and is characterized by the fact that expression of CD44, SOX2, CIRBP genes in glial tumour tissues is measured, and tumour grade is assessed by “y” value calculated on the basis of obtained expression values of said genes.
EFFECT: simplification and higher accuracy of the method for differential diagnosis of glial tumours of grade III and IV.
1 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING THE DEGREE OF CELL ANAPLASIA IN THE GLIOMA CULTURE | 2021 |
|
RU2780236C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF HIGH GRADE GLIOMAS | 2022 |
|
RU2786003C1 |
| METHOD FOR ASSESSING CELL MALIGNANCY IN GLIOMA CULTURES | 2022 |
|
RU2786007C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF GLIOMAS BASED ON ANALYSIS OF GENE EXPRESSION AND MICRO-RNA | 2018 |
|
RU2709651C1 |
| METHOD FOR DIAGNOSING GLIAL BRAIN TUMORS OF HIGH DEGREE OF MALIGNANCY | 2020 |
|
RU2742413C1 |
| METHOD FOR MINIMALLY INVASIVE DIAGNOSIS OF MENINGIOMAS AND GLIAL TUMORS WITH SPECIFICATION OF THE DEGREE OF MALIGNANCY | 2022 |
|
RU2788814C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF GLIOMAS OF HUMAN BRAIN | 2015 |
|
RU2583871C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF GLIAL BRAIN TUMORS | 2020 |
|
RU2743223C1 |
| METHOD FOR MINIMALLY INVASIVE DIAGNOSIS OF GLIOBLASTOMAS | 2022 |
|
RU2788815C1 |
| METHOD FOR PREDICTION OF EVOLUTION OF CEREBRAL GLIOMAS | 2020 |
|
RU2740194C1 |
